|
![]() |
|||
|
||||
OverviewHepatitis C Virus is a quickly evolving area within hepatology owing to new medical therapies. This issue, guest edited by Dr. Fred Poordad, includes the most current clinical information and treatment therapies. Expert authors have written review articles devoted to the following medical therapies: Boceprevir, Telaprevir, Protease Inhibitors in Development, NS5B Nucleoside and Non-Nucleoside Inhibitors. Review articles also address important patients like naïve- and non-responders and relapsers, the HIV co-infected patient, and the Genotype 1 and non-Genotype 1 patient. Full Product DetailsAuthor: Fred Poordad (University of Texas Health Science Center, San Antonio, Texas)Publisher: Elsevier Health Sciences Imprint: W B Saunders Co Ltd Volume: 15-3 Dimensions: Width: 15.20cm , Height: 1.80cm , Length: 22.90cm Weight: 0.460kg ISBN: 9781455711079ISBN 10: 1455711071 Publication Date: 22 December 2011 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |